The Drug Administration of Vietnam under the Ministry of Health on February 17 granted permission for circulation of three drugs containing Molnupiravir manufactured in Vietnam for the treatment of Covid-19.
A number of antiviral drugs specifically for COVID-19 treatment such as Molnupiravir and Favipiravir are being traded on the black market locally at various prices and with unreliable quality, though they are strictly prescribed by doctors.
As the battle against COVID rages on, some are taking advantage of the anxiety and worry of others to make a fast buck, no matter the consequences.
An advisory council of the Ministry of Health (MoH) has proposed this ministry grant certificates of registration for conditional circulation of three medicines containing the active ingredient molnupiravir for COVID-19 treatment.
Health professionals of the Ministry of Health are due to meet on January 5 to consider licensing local pharmaceutical companies that produce Molnupiravir for COVID-19 treatment.
The Ministry of Health on Wednesday added three antiviral drugs - Molnupiravir 400 mg, remdesivir and favipiravir to its latest COVID-19 treatment protocol.
Deputy Minister of Health Tran Van Thuan held an online working session with France’s Xenothera company on cooperation to conduct the third phase of clinical trial of Xenothera-developed XAV-19 COVID-19 treatment drug
The HCM City Department of Health has asked the Medical Examination and Treatment Administration and the Drug Administration of Vietnam to approve the use of Reamberin and Cytoflavin drugs in the treatment of Covid-19 patients.
A locally developed Covid-19 treatment drug called Vipdervir will be tested on 260 Covid-19 patients.
The Ministry of Health on July 26 decided to withdraw dispatch 5944 only two days after its issuance because of inappropriate content.